
High-resolution X-ray scanning enables whole-body and regional assessment of bone mineral density and changes in bone structure, supporting efficacy evaluation in osteoporosis and other bone metabolism studies.
Quantitative analysis of fat mass, lean tissue, and body composition helps distinguish the sources of weight change and evaluate treatment effects in metabolic disease studies.
DEXA supports both in vivo animal imaging and ex vivo tissue analysis, enabling researchers to correlate longitudinal phenotypic changes with tissue-level findings.
Noninvasive imaging enables repeated measurements in the same animals over time, supporting longitudinal analysis while potentially reducing the number of animals required.
The in vivo optical imaging system captures and quantifies bioluminescent and fluorescent signals in living organisms, enabling real-time, non-invasive monitoring of tumor progression, metastatic spread, drug distribution, and various physiological processes in mouse models. The platform supports drug efficacy evaluation and pharmacokinetic analysis.
Cardiac Structure Assessment: High-resolution ultrasound imaging measures parameters including left ventricular internal diameter and ventricular wall thickness to assess cardiac size and structure.
Cardiac Function Assessment: Measurement of parameters including left ventricular ejection fraction and fractional shortening supports evaluation of systolic and diastolic cardiac function.
Liver Ultrasound: Assessment of liver size, shape, and internal echogenicity supports the detection and evaluation of liver abnormalities.
Kidney Ultrasound: Assessment of kidney size, cortical thickness, and structural abnormalities such as hydronephrosis supports evaluation of renal structure.
Carotid Artery Blood Flow Detection: Coronary artery blood flow measurements support cardiovascular disease studies and evaluation of therapeutic effects.
Coronary Artery Blood Flow Detection: Echocardiography enables measurement of coronary artery blood flow to support cardiovascular disease research and evaluation of therapeutic effects.
Tail Artery Blood Pressure Measurement: Noninvasive tail artery measurement enables longitudinal monitoring of blood pressure in mice, including changes associated with drug intervention and disease progression.
The ultrasound analysis platform provides high-precision image recognition and quantitative data analysis. Measurements including organ dimensions and hemodynamic parameters support detailed assessment of cardiovascular function and organ status in mouse models.
Precision: High-resolution measurement of bone mineral density and body composition
Noninvasive Analysis: Minimal animal handling for repeated measurements
Reproducibility: Consistent data across longitudinal studies
Image Quality: High-resolution imaging for detailed anatomical and body composition analysis
The system generates comprehensive imaging outputs, including high-resolution X-ray images, bone mineral density (BMD) maps, and pseudo-colored body composition visualizations enabling multi-dimensional analysis in a single scan.
X-Ray Imaging: High-resolution radiographs support precise measurement of regional bone length, fracture assessment, and implant localization with exceptional clarity.
Bone Mineral Density Mapping: Quantitative BMD visualization highlights density distribution across skeletal regions, facilitating early detection of bone loss and treatment response evaluation.
Body Composition Analysis: Pseudo-colored imaging distinguishes fat, lean tissue, and bone mass, providing an intuitive overview of physiological changes in metabolic and aging studies.
![]() | ![]() | ![]() |
| X-ray images | BMD Images | BMD Images |
BMD | BMC | Bone Area | Tissue Area | Fat(%%) | Fat(g) | Lean(g) |
0.087 | 0.553 | 6.33 | 16.507 | 14.104 | 3.294 | 20.061 |
![]() | ![]() | ![]() |
Isolated bone tissue
BMD | BMC | Bone Area | Tissue Area | Fat(%) | Fat(g) | Lean(g) |
0.034 | 0.001 | 0.017 | 0.267 | 4 | 0.005 | 0.128 |
0.016 | 0.004 | 0.22 | 3.181 | 32.037 | 0.591 | 1.253 |
Broad Coverage: Large field of view for simultaneous imaging of multiple regions
High Throughput: Multi-animal imaging for efficient study execution
Multimodal Imaging: Integrated fluorescence and bioluminescence capabilities
Quantitative Analysis: Absolute signal intensity quantification for rigorous data analysis
In vivo optical imaging enabled real-time monitoring of drug distribution, accumulation, and clearance in live animals across multiple time points.





![]()


Let us know which event you're attending and we'd be happy to connect with you.